{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:10:13Z","timestamp":1789985413906,"version":"4.0.1"},"reference-count":22,"publisher":"FapUNIFESP (SciELO)","issue":"2","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"DOI":"10.1590\/1414-431x20165958","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T13:30:47Z","timestamp":1487597447000},"source":"Crossref","is-referenced-by-count":20,"title":["Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases"],"prefix":"10.1590","volume":"50","author":[{"given":"Y.","family":"Xia","sequence":"first","affiliation":[{"name":"Shenzhen Children\u2019s Hospital,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cui","sequence":"additional","affiliation":[{"name":"Shenzhen Children\u2019s Hospital,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Li","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Chongqing Medical University,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Liang","sequence":"additional","affiliation":[{"name":"Shenzhen Children\u2019s Hospital,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Li","sequence":"additional","affiliation":[{"name":"Shenzhen Children\u2019s Hospital,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Yang","sequence":"additional","affiliation":[{"name":"Shenzhen Children\u2019s Hospital,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2017]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli A","year":"2007","journal-title":"Lancet"},{"key":"ref2","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty RE","year":"2004","journal-title":"J Rheumatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1002\/art.20631","article-title":"Proinflammatory S100 proteins in arthritis and autoimmune disease","volume":"50","author":"Foell D","year":"2004","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2012.11.008","article-title":"Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers","volume":"147","author":"Kessel C","year":"2013","journal-title":"Clin Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autrev.2012.07.022","article-title":"Systemic juvenile idiopathic arthritis","volume":"12","author":"Martini A","year":"2012","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"271569","DOI":"10.1155\/2012\/271569","article-title":"Systemic arthritis in children: a review of clinical presentation and treatment","volume":"2012","author":"Gurion R","year":"2012","journal-title":"Int J Inflam"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1002\/pmic.201000298","article-title":"Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications","volume":"10","author":"Ling XB","year":"2010","journal-title":"Proteomics"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","article-title":"Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions","volume":"7","author":"Mellins ED","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/CE.S5992","article-title":"Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis","volume":"4","author":"Herlin T","year":"2009","journal-title":"Core Evid"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/annrheumdis-2011-200598","article-title":"The Toll-like receptor 4 agonist MRP8\/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis","volume":"71","author":"Holzinger D","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/art.24349","article-title":"The myeloid-related proteins 8 and 14 complex, a novel ligand of Toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"Frosch M","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/icb.2009.88","article-title":"S100 Calgranulins in inflammatory arthritis","volume":"88","author":"Perera C","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nm1638","article-title":"Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock","volume":"13","author":"Vogl T","year":"2007","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1471-4906(03)00062-0","article-title":"Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules","volume":"24","author":"Roth J","year":"2003","journal-title":"Trends Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X","article-title":"Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis","volume":"43","author":"Frosch M","year":"2000","journal-title":"Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.smim.2013.10.014","article-title":"Interleukin-18,more than a Th1 cytokine","volume":"25","author":"Novick D","year":"2013","journal-title":"Semin Immunol"},{"key":"ref17","first-page":"823","article-title":"Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis","volume":"34","author":"Lotito AP","year":"2007","journal-title":"J Rheumatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","article-title":"Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study","volume":"66","author":"de Jager W","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00296-014-3059-2","article-title":"Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease","volume":"35","author":"Takahara T","year":"2015","journal-title":"Rheumatol Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1007\/s00296-012-2623-x","article-title":"Association of interleukin-18 and systemic lupus erythematosus","volume":"33","author":"Xu WD","year":"2013","journal-title":"Rheumatol Int"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2174\/13894501113149990006","article-title":"Clinical strategies for the blockade of IL-18 in inflammatory bowel diseases","volume":"14","author":"Kanai T","year":"2013","journal-title":"Curr Drug Targets"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1182\/blood-2014-01-546713","article-title":"Targeting cytokines in ALPS: it's FAShionable","volume":"123","author":"Teachey DT","year":"2014","journal-title":"Blood"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bjmbr\/v50n2\/1414-431X-bjmbr-1414-431X20165958.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T15:41:43Z","timestamp":1581090103000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2017000200703&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017]]}},"alternative-id":["S0100-879X2017000200703"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x20165958","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"value":"1414-431X","type":"electronic"},{"value":"0100-879X","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]},"article-number":"e5958"}}